Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa

Publisher： Bentham Science Publishers

E-ISSN： 1877-9131|4|1|15-24

ISSN： 1877-9123

Source： Recent Patents on Nanomedicine, Vol.4, Iss.1, 2014-06, pp. : 15-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 769-773

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 821-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 821-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidemiology of inherited epidermolysis bullosa in Romania and genotype–phenotype correlations in patients with dystrophic epidermolysis bullosa

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 5, 2015-05 ,pp. : 899-903

John Wiley & Sons Inc

Access to resources Recommend Favorite

Purified Type I Collagen Wound Matrix Improves Chronic Wound Healing in Patients with Recessive Dystrophic Epidermolysis Bullosa

By  

PEDIATRIC DERMATOLOGY, Vol. 32, Iss. 2, 2015-03 ,pp. : 220-225

John Wiley & Sons Inc

Access to resources Recommend Favorite